Stockholders' Equity (Details) - USD ($)				1 Months Ended	12 Months Ended
	May 03, 2024	Jun. 14, 2023	Jun. 09, 2023	Jul. 31, 2023	Mar. 31, 2024	Mar. 31, 2023	Dec. 08, 2023	Oct. 11, 2021	Jul. 31, 2020
Stockholders’ Equity (Deficit) (Details) [Line Items]
Reverse stock split description			1-for-20 reverse stock split
Shares of common stock		2,150,000
Dividends preferred stock (in Dollars)					$ 100,000	$ 100,000
Net proceeds from from common stock					8,524,000
Pre-funded warrants exercise price		$ 0.001
Pre-funded warrants to purchase common stock		516,667
Combined purchase price per share		$ 3
Aggregate gross proceeds from equity financing		$ 8,000,000
Stock issued value					$ 7,439,000
Stock dividends					196,000	37,000
Treasury stock shares					288,554	65,792
Weighted average fair value of outstanding grants					$ 4.99	$ 8.52
Share-based payment arrangement, option, exercise price range, outstanding, weighted average exercise price (in Dollars per share)					$ 290	$ 287
Options expired					9,000
Granted shares					207,000
Maturity date					10 years
Warrants to Purchase Common Stock		2,666,667
Selling, General and Administrative Expenses [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Stock-based compensation					$ 1,400,000	$ 4,800,000
Performance Stock Units [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Shares granted					0
Shares issued					0
Shares remained unvested						16,000
Stock Appreciation Rights (SARs) [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Compensation cost not yet recognized related to nonvested awards					$ 703,000
Weighted average remaining vesting period					9 months 18 days
Equity Incentive Plan [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Percent voting power threshold					10.00%
Exercise price if voting threshold is met, percent					110.00%
Common Stock [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Common stock, shares authorized								275,000,000
Shares of common stock					6,400,000	582,000
ATM Sales Agreement [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Aggregate offering price									$ 30,000,000
Net proceeds from from common stock					$ 1,100,000
ATM Sales Agreement [Member] | Common Stock [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Shares of common stock					177,000
Sales Agreement [Member] | Subsequent Event [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Percentage of aggregate gross proceeds from each sale of shares	3.00%
Sales Agreement [Member] | Common Stock [Member] | Subsequent Event [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Aggregate offering price	$ 15,000,000
Exercise of Pre-Funded Warrants [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Gross proceeds from warrants exercised				$ 500
Class A Common Stock [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Common stock, shares authorized					275,000,000	275,000,000
Common stock, par value and per share (in Dollars per share)					$ 0.001	$ 0.001
Number of shares award							2,055,000
Class A Common Stock [Member] | Common Stock [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Number of stock issued					2,150,000
Stock issued value					$ 2,000
Common stock, acquired						391,000
Preferred Stock Dividends, Shares						37,000
Class A Common Stock [Member] | Sales Agreement [Member] | Subsequent Event [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Common stock, par value and per share (in Dollars per share)	$ 0.001
Board of Directors [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Shares issued					400,000	34,000
Board of Directors [Member] | Restricted Stock Awards [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Stock based compensation (in Dollars)					$ 300,000	$ 400,000